Sex steroids do not alter sex differences in tyrosine hydroxylase activity of dopaminergic neurons in vitro.
In order to distinguish the effects of genetic sex from those of sex hormones on the sexual differentiation of dopaminergic neurons, catecholamine synthesis was studied in gender-specific cultures of embryonic day-14 rat diencephalon. In addition to embryos from normal dams, embryos were used whose mothers had been treated with the estrogen antagonist tamoxifen or the testosterone antagonist cyproterone acetate on days 12 and 13 of gestation. Cultures from embryos of untreated dams were fed daily with a medium containing 17 beta-estradiol or testosterone. After 10 days in vitro, cultures were immunostained for tyrosine hydroxylase and the accumulation of dihydroxyphenylalanine (DOPA) was measured in the presence of the DOPA decarboxylase inhibitor NSD 1015. Rates of DOPA synthesis, unlike the numbers of tyrosine hydroxylase-immunoreactive neurons, were markedly higher in female cultures under all experimental conditions. Treatment of dams with antisteroids prior to removal of the embryos had no influence on these results. Treatment of cultures with both steroids decreased DOPA formation in a dose-dependent manner without altering the sex difference. These results suggest that cultured diencephalic dopaminergic neurons develop sex differences in the activity of tyrosine hydroxylase. This sexual dimorphism is initiated independently on the activity of gonadal steroid hormones. Sex hormones exert an additional modulatory influence on the activity of the enzyme but do not abolish or reverse sex differences. Therefore, the concept of a purely epigenetic mode of sexual differentiation of the mammalian brain needs to be broadened to incorporate other mechanisms, such as the cell-autonomous fulfillment of a sex-specific genetic program.
Beyer
C
C
Abteilung Anatomie und Zellbiologie Universität, Albert-Einstein, Ulm, Federal Republic of Germany.
Eusterschulte
B
B
Pilgrim
C
C
Reisert
I
I
D000818:Animals; D002478:Cells, Cultured / Q000187:drug effects; D017373:Cyproterone Acetate / Q000494:pharmacology; D004027:Diencephalon / Q000187:drug effects* / Q000196:embryology; D004295:Dihydroxyphenylalanine / Q000096:biosynthesis*; D004622:Embryo, Mammalian / Q000166:cytology; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D012739:Gonadal Steroid Hormones / Q000494:pharmacology*; D008297:Male; D009474:Neurons / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D017207:Rats, Sprague-Dawley; D012733:Sex Differentiation / Q000187:drug effects*; D013629:Tamoxifen / Q000494:pharmacology; D013739:Testosterone / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D012739:Gonadal Steroid Hormones; D013629:Tamoxifen; D013739:Testosterone; D017373:Cyproterone Acetate; D004958:Estradiol; D004295:Dihydroxyphenylalanine; D014446:Tyrosine 3-Monooxygenase